» Articles » PMID: 29877283

Increased Serum Dihomo-γ-linolenic Acid Levels Are Associated with Obesity, Body Fat Accumulation, and Insulin Resistance in Japanese Patients with Type 2 Diabetes

Overview
Journal Intern Med
Specialty General Medicine
Date 2018 Jun 8
PMID 29877283
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Objective To clarify the associations between serum omega-6 (n-6) and omega-3 (n-3) polyunsaturated fatty acid (PUFA) levels and obesity-related metabolic abnormalities in patients with type 2 diabetes. Methods and Materials Data from 225 Japanese patients with type 2 diabetes were cross-sectionally analyzed. The serum levels of n-6 PUFAs [dihomo-γ-linolenic acid (DGLA) and arachidonic acid (AA)] and n-3 PUFAs (eicosapentaenoic acid and docosahexaenoic acid) were measured, and the estimated Δ-5 desaturase (D5D) activity was calculated based on the AA to DGLA ratio. The associations between the composition of PUFAs and obesity-related parameters, including the body mass index (BMI), waist circumference, alanine amino transferase (ALT) level, homeostatic model assessment of insulin resistance (HOMA-IR), and body fat percentage, as measured by a bioelectrical impedance analysis, were analyzed. Results Among the PUFAs, the DGLA level had the strongest correlations with BMI (p<0.001), waist circumference (p<0.001), ALT level (p<0.001), HOMA-IR (p<0.001), and body fat percentage (p<0.01). AA was positively correlated and D5D was negatively correlated with several obesity-related parameters, while n-3 PUFAs did not have a constant correlation. A multivariate regression analysis revealed that the DGLA level was an independent determinant for HOMA-IR (β=0.195, p=0.0066) after adjusting for sex, age, BMI, and the ALT, triglyceride, and HbA1c levels. Conclusion A high serum DGLA level was associated with obesity, body fat accumulation, a high ALT level, and insulin resistance in patients with type 2 diabetes. The measurement of the serum PUFA levels may be useful for evaluating metabolic abnormalities and estimating the dietary habits of patients.

Citing Articles

High levels of serum dihomo-γ-linolenic acid are associated with non-alcoholic fatty liver disease in type 2 diabetic patients.

Mochizuki K, Higa M, Ikehara K, Ichijo T, Hirose T Diabetol Int. 2025; 16(1):107-114.

PMID: 39877445 PMC: 11769884. DOI: 10.1007/s13340-024-00760-3.


Oxylipins Derived from PUFAs in Cardiometabolic Diseases: Mechanism of Actions and Possible Nutritional Interactions.

Agagunduz D, Yesildemir O, Kocyigit E, Kocak T, Ozen Unaldi B, Ayakdas G Nutrients. 2024; 16(22).

PMID: 39599599 PMC: 11597274. DOI: 10.3390/nu16223812.


Relationship between Polyunsaturated Fatty Acid Metabolism and Atherosclerosis.

Liu Q, Liu Z, Wu D, Wang S Rev Cardiovasc Med. 2024; 25(4):142.

PMID: 39076540 PMC: 11263998. DOI: 10.31083/j.rcm2504142.


Serum Metabolomics Uncovers the Mechanisms of Inulin in Preventing Non-Alcoholic Fatty Liver Disease.

Sun Y, Zhou W, Zhu M Pharmaceuticals (Basel). 2024; 17(7).

PMID: 39065745 PMC: 11279973. DOI: 10.3390/ph17070895.


Association of dietary nutrient intake with type 2 diabetes: A Mendelian randomization study.

Kang R, Guo D, Wang J, Xie Z Medicine (Baltimore). 2024; 103(19):e38090.

PMID: 38728475 PMC: 11081547. DOI: 10.1097/MD.0000000000038090.


References
1.
Simopoulos A . Essential fatty acids in health and chronic disease. Am J Clin Nutr. 1999; 70(3 Suppl):560S-569S. DOI: 10.1093/ajcn/70.3.560s. View

2.
Yanagisawa N, Shimada K, Miyazaki T, Kume A, Kitamura Y, Ichikawa R . Polyunsaturated fatty acid levels of serum and red blood cells in apparently healthy Japanese subjects living in an urban area. J Atheroscler Thromb. 2010; 17(3):285-94. DOI: 10.5551/jat.2618. View

3.
Hennig B, Watkins B . Linoleic acid and linolenic acid: effect on permeability properties of cultured endothelial cell monolayers. Am J Clin Nutr. 1989; 49(2):301-5. DOI: 10.1093/ajcn/49.2.301. View

4.
An W, Son Y, Kim S, Kim K, Bae H, Lee S . Association of adiponectin and leptin with serum lipids and erythrocyte omega-3 and omega-6 fatty acids in dialysis patients. Clin Nephrol. 2011; 75(3):195-203. DOI: 10.5414/cnp75195. View

5.
Vessby B, Gustafsson I, Tengblad S, Boberg M, Andersson A . Desaturation and elongation of Fatty acids and insulin action. Ann N Y Acad Sci. 2002; 967:183-95. DOI: 10.1111/j.1749-6632.2002.tb04275.x. View